AR076478A1 - Proceso para la preparacion de [4-(2-cloro-4-metoxi-5-metilfenil)-5-metil-tiazolo-2-il]-[2-ciclopropil-1-(3-fluoro-4-metilfenil)-etil]-amina - Google Patents

Proceso para la preparacion de [4-(2-cloro-4-metoxi-5-metilfenil)-5-metil-tiazolo-2-il]-[2-ciclopropil-1-(3-fluoro-4-metilfenil)-etil]-amina

Info

Publication number
AR076478A1
AR076478A1 ARP100101422A ARP100101422A AR076478A1 AR 076478 A1 AR076478 A1 AR 076478A1 AR P100101422 A ARP100101422 A AR P100101422A AR P100101422 A ARP100101422 A AR P100101422A AR 076478 A1 AR076478 A1 AR 076478A1
Authority
AR
Argentina
Prior art keywords
methylphenyl
fluoro
chloro
methyl
preparation
Prior art date
Application number
ARP100101422A
Other languages
English (en)
Inventor
Zsolt Parkanyi
Janos Fazekas
Peter Miskolczi
Annamaria Molnar
Bela Agai
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of AR076478A1 publication Critical patent/AR076478A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/02—Thiocyanates
    • C07C331/04—Thiocyanates having sulfur atoms of thiocyanate groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F216/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical
    • C08F216/12—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical by an ether radical
    • C08F216/14—Monomers containing only one unsaturated aliphatic radical
    • C08F216/1466—Monomers containing sulfur
    • C08F216/1483—Monomers containing sulfur and nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

Reivindicacion 1: Un proceso para la preparacion de la [4-(2-cloro-4-metoxi-5-metilfenil) -5-metil-tiazolo-2-il] - [2-ciclo-propil-1-(3-fluoro-4-metilfenil)-etil)-amina de la formula (1): caracterizado porque: a) el compuesto de la formula general (2) en la cual X significa halogeno, se hace reaccionar con un tiocianato de metal alcalino, en presencia de un catalizador de transferencia de fases, y b) la 2-tiocianato-1-(2-cloro-4-metoxi-5-metilfenil) - propan-1-ona obtenida de esta manera de la formula (3): o una forma tautomérica de la misma se hace reaccionar con la 2-ciclopropil-1-(3-fluoro-4-metilfenil)-etil-amina de la formula (4).
ARP100101422A 2009-04-30 2010-04-28 Proceso para la preparacion de [4-(2-cloro-4-metoxi-5-metilfenil)-5-metil-tiazolo-2-il]-[2-ciclopropil-1-(3-fluoro-4-metilfenil)-etil]-amina AR076478A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0900267A HUP0900267A2 (en) 2009-04-30 2009-04-30 Process for preparing of thiazole amines and intermediates thereof

Publications (1)

Publication Number Publication Date
AR076478A1 true AR076478A1 (es) 2011-06-15

Family

ID=89988941

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100101422A AR076478A1 (es) 2009-04-30 2010-04-28 Proceso para la preparacion de [4-(2-cloro-4-metoxi-5-metilfenil)-5-metil-tiazolo-2-il]-[2-ciclopropil-1-(3-fluoro-4-metilfenil)-etil]-amina

Country Status (19)

Country Link
US (1) US8314249B2 (es)
EP (1) EP2424848B1 (es)
JP (1) JP5608221B2 (es)
KR (1) KR20120014005A (es)
CN (1) CN102414185B (es)
AR (1) AR076478A1 (es)
AU (1) AU2010243362B2 (es)
BR (1) BRPI1014627A2 (es)
CA (1) CA2760384A1 (es)
HU (1) HUP0900267A2 (es)
IL (1) IL216017A0 (es)
IN (1) IN2011KN04192A (es)
MX (1) MX2011011530A (es)
MY (1) MY152269A (es)
RU (1) RU2523793C2 (es)
SG (1) SG175829A1 (es)
TW (1) TWI461413B (es)
UY (1) UY32594A (es)
WO (1) WO2010125414A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8943551B2 (en) * 2008-08-14 2015-01-27 Microsoft Corporation Cloud-based device information storage
HUP0900267A2 (en) 2009-04-30 2011-03-28 Sanofi Aventis Process for preparing of thiazole amines and intermediates thereof
CA3155599A1 (en) 2014-01-21 2015-07-30 Neurocrine Biosciences, Inc. Crf1 receptor antagonists for the treatment of congenital adrenal hyperplasia
US10207974B1 (en) 2017-12-05 2019-02-19 Chevron Phillips Chemical Company Lp Synthesis of gamma dicarbonyl and pyrrole compounds
WO2020115555A2 (en) 2018-12-07 2020-06-11 Neurocrine Biosciences, Inc. Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia
CN114502162A (zh) * 2019-09-27 2022-05-13 纽罗克里生物科学有限公司 Crf受体拮抗剂及使用方法
JOP20220329A1 (ar) 2020-06-10 2023-01-30 مضاد مستقبل crf1 لعلاج فرط تنسج الكظر الخلقي

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB823251A (en) 1955-07-02 1959-11-11 Thomae Gmbh Dr K Improvements in or relating to preparations containing benzoxathiol derivatives for the care of hair and skin
US3222248A (en) * 1961-12-12 1965-12-07 Stauffer Chemical Co Method of controlling microorganisms by means of organic thiocyanates
US3433803A (en) 1966-12-01 1969-03-18 Olin Mathieson Substituted imino-1,3-oxathiols and their preparation
IL103586A (en) 1991-10-30 1997-09-30 Astra Ab Process for the preparation of 4-methyl-5- (2-chloroethyl)-thiazole and analogues thereof
JPH1036360A (ja) 1996-02-21 1998-02-10 Kuraray Co Ltd ２−クロロ−５−クロロメチル−１，３−チアゾールの製造方法
FR2796380B3 (fr) * 1999-07-15 2001-08-17 Sanofi Synthelabo Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
HUP0900267A2 (en) 2009-04-30 2011-03-28 Sanofi Aventis Process for preparing of thiazole amines and intermediates thereof

Also Published As

Publication number Publication date
TWI461413B (zh) 2014-11-21
RU2523793C2 (ru) 2014-07-27
JP5608221B2 (ja) 2014-10-15
HU0900267D0 (en) 2009-07-28
MX2011011530A (es) 2011-11-18
BRPI1014627A2 (pt) 2015-08-25
CN102414185A (zh) 2012-04-11
US8314249B2 (en) 2012-11-20
EP2424848A1 (en) 2012-03-07
US20120083608A1 (en) 2012-04-05
IL216017A0 (en) 2012-01-31
EP2424848B1 (en) 2013-03-13
MY152269A (en) 2014-09-15
CN102414185B (zh) 2014-02-26
WO2010125414A8 (en) 2011-04-07
TW201105640A (en) 2011-02-16
IN2011KN04192A (es) 2015-10-02
KR20120014005A (ko) 2012-02-15
SG175829A1 (en) 2011-12-29
WO2010125414A1 (en) 2010-11-04
AU2010243362A1 (en) 2011-11-17
JP2012525368A (ja) 2012-10-22
HUP0900267A2 (en) 2011-03-28
AU2010243362B2 (en) 2015-07-30
RU2011148584A (ru) 2013-06-10
CA2760384A1 (en) 2010-11-04
UY32594A (es) 2010-11-30

Similar Documents

Publication Publication Date Title
AR076478A1 (es) Proceso para la preparacion de [4-(2-cloro-4-metoxi-5-metilfenil)-5-metil-tiazolo-2-il]-[2-ciclopropil-1-(3-fluoro-4-metilfenil)-etil]-amina
SMP200900085B (it) 3-imidazolil-indoli per il trattamento di malattieproliferative.
DK3686193T3 (da) 2-(2,4,5-substitueret anilino)pyrimidinforbindelser
CO6801792A2 (es) Formas cristalinas de 5-cloro-n2-(2-isoporpoxi 5-metil-4-piperidin-4-il-fenil)-n4-[2-(propan-2-sulfonil)-fenil]-pirimidin-2,4-diamina.
EA201490252A1 (ru) Катализатор и способ его получения
EE200800048A (et) Deformeeritud metallesemete tootmise meetodid
DK3309139T3 (da) Process for the preparation of 2,3,3,3-trifluoropropene
MA32998B1 (fr) Chlorhydrate de n-{(1-s)-2-amino-1-[(3-fluorophényl) méthyl]éthyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophènecarboxamide cristallin
BRPI0814809A2 (pt) Compostos di(arilamino)arílicos
RS52255B (en) NALMEFEN HYDROCHLORIDE DIHYDRATE
BRPI0918472A2 (pt) composto 2,4-diaminopirimidina
DK1934327T3 (da) Mikroorganismer, der hæmmer dannelsen af armhulelugt
CU20090141A7 (es) Compuestos 2-amino pirimidina
BRPI1014691A2 (pt) Composto, e, processo para a preparação de um composto.
CL2012000493A1 (es) Procedimiento de preparacion de 2-alquilamino-3-piridin-n-bencilpiperazin cetonas.
IT1399347B1 (it) Protesi d'anca di nuova concezione.
WO2011033115A3 (en) Compounds useful against kinetoplastideae parasites
IT1398376B1 (it) Nuove composizioni per il trattamento di leucemie chemioresistenti e/o di leucemie potenzialmente chemioresistenti.
BRPI0816810A2 (pt) utilização de pelo menos um composto, e, composto.
RU2010130104A (ru) 2-(1'-гидрокси-4'-изопропилен-1'-метилциклогексил-2'-тио)-метилэтаноат, обладающий фунгицидным и противовоспалительным действием
ITVI20080110A1 (it) Struttura di ortesi, particolarmente per caviglia-piede.
IT1396556B1 (it) Uso di memantina per il trattamento di disturbi dell umore
RU2009100631A (ru) 2-гидрокси-4-оксо-4-фенил-2-бутеноат бензотиазолиламмония, обладающий гипогликемической активностью
ES1060108Y (es) Instalacion para produccion de articulos de cuarzo.
IT1396108B1 (it) Supporto asolato per la realizzazione di infissi dotati di alette spioventi.

Legal Events

Date Code Title Description
FB Suspension of granting procedure